New patent for Strongbridge drug RECORLEV
Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. There are six patents protecting this drug. This drug has twenty-eight…
The post New patent for Strongbridge drug RECORLEV appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.